Author Page for David M. Shackleford

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Design, Synthesis and Evaluation of Novel 2-Phenyl-3-(1H-Pyrazol-4-yl)Pyridine Positive Allosteric Modulators for the M4 mAChR

Number of pages: 59 Posted: 04 May 2023

Manuela Jörg, Emma T. van der Westhuizen, Yao Lu, K. H. Christopher Choy, David M. Shackleford, Elham Khajehali, Andrew Tobin, David Thal, Ben Capuano, Arthur Christopoulos, Celine Valant and Peter Scammells

Monash University - Monash Institute of Pharmaceutical Sciences, Monash University - Drug Discovery Biology, Monash University - Monash Institute of Pharmaceutical Sciences, Monash University - Monash Institute of Pharmaceutical Sciences, Monash University - Monash Institute of Pharmaceutical Sciences, Monash University - Monash Institute of Pharmaceutical Sciences, University of Glasgow - The Centre for Translational Pharmacology, Monash University - Drug Discovery Biology, Monash University - Monash Institute of Pharmaceutical Sciences, Monash University - Drug Discovery Biology, Monash University - Drug Discovery Biology and Monash University - Monash Institute of Pharmaceutical Sciences

Downloads 30 (1,318,317)

David M. Shackleford

Monash University - Monash Institute of Pharmaceutical Sciences

1

30

0

Scholarly Papers (1)

Design, Synthesis and Evaluation of Novel 2-Phenyl-3-(1H-Pyrazol-4-yl)Pyridine Positive Allosteric Modulators for the M4 mAChR

Abstract: